Ningbo David Medical Device Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001DD1
CNY
11.76
0.16 (1.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
580.52
524.47
613.21
501.56
470.63
455.87
353.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
580.52
524.47
613.21
501.56
470.63
455.87
353.69
Raw Material Cost
282.74
243.32
275.72
223.70
196.10
200.44
173.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
120.85
117.79
111.31
94.40
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.86
0.86
0.93
0.62
0.27
0.26
0.29
Selling and Distribution Expenses
166.11
161.45
161.55
144.81
155.28
115.59
89.33
Other Expenses
-6.43
-6.58
-6.64
-5.15
4.69
3.76
3.79
Total Expenditure (Excl Depreciation)
506.31
457.61
483.14
412.02
398.52
353.87
300.86
Operating Profit (PBDIT) excl Other Income
74.2
66.9
130.1
89.5
72.1
102
52.800000000000004
Other Income
19.63
22.15
39.04
42.55
15.54
14.70
18.72
Operating Profit (PBDIT)
119.27
108.65
192.68
153.65
105.74
135.16
87.84
Interest
0.86
0.86
0.93
0.62
0.27
0.26
0.29
Exceptional Items
1.96
0.19
-1.26
0.90
1.83
0.00
-0.85
Gross Profit (PBDT)
297.77
281.16
337.50
277.85
274.53
255.43
180.39
Depreciation
29.56
27.24
27.41
25.51
24.55
21.49
21.08
Profit Before Tax
90.81
80.75
163.08
128.42
82.76
113.41
65.62
Tax
11.60
6.12
18.61
14.56
6.99
10.46
7.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
87.05
57.26
147.61
97.36
80.21
136.19
62.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
87.05
57.26
147.61
97.36
80.21
136.19
62.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
87.05
57.26
147.61
97.36
80.21
136.19
62.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,232.98
1,168.32
1,163.47
1,059.06
990.53
953.52
828.85
Earnings per share (EPS)
0.3
0.2
0.51
0.34
0.28
0.47
0.22
Diluted Earnings per share
0.3
0.2
0.51
0.34
0.28
0.47
0.22
Operating Profit Margin (Excl OI)
12.07%
11.3%
20.59%
17.06%
13.95%
21.71%
13.58%
Gross Profit Margin
20.73%
20.59%
31.06%
30.69%
22.8%
29.59%
24.51%
PAT Margin
15.0%
10.92%
24.07%
19.41%
17.04%
29.87%
17.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 10.68% vs -14.47% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 52.01% vs -61.18% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 15.14% vs -43.68% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Ningbo David Medical Device Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
580.52
0
580.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
580.52
0
580.52
Raw Material Cost
282.74
0
282.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
120.85
0
120.85
Power Cost
0
0
0.00
Manufacturing Expenses
0.86
0
0.86
Selling and Distribution Expenses
166.11
0
166.11
Other Expenses
-6.43
0.00
-6.43
Total Expenditure (Excl Depreciation)
506.31
0
506.31
Operating Profit (PBDIT) excl Other Income
74.21
0.00
74.21
Other Income
19.63
0
19.63
Operating Profit (PBDIT)
119.27
0
119.27
Interest
0.86
0
0.86
Exceptional Items
1.96
0
1.96
Gross Profit (PBDT)
297.77
0
297.77
Depreciation
29.56
0
29.56
Profit Before Tax
90.81
0
90.81
Tax
11.60
0
11.60
Provisions and contingencies
0
0
0.00
Profit After Tax
87.05
0
87.05
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
87.05
0
87.05
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
87.05
0
87.05
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,232.98
0
1,232.98
Earnings per share (EPS)
0.30
0
0.30
Diluted Earnings per share
0.30
0
0.30
Operating Profit Margin (Excl OI)
12.07%
0%
0.00
12.07%
Gross Profit Margin
20.73%
0%
0.00
20.73%
PAT Margin
15.00%
0%
0.00
15.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 58.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 10.68% vs -14.47% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 8.71 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 52.01% vs -61.18% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.96 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 15.14% vs -43.68% in Dec 2024

Annual - Interest
Interest 0.09 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.07%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024